BRIEF-3D Signatures says completion of Stage 3 of Hodgkin’s Lymphoma Test Validation Program

* ‍On September 30, co completed clinical trial component or stage 3, of its Hodgkin's Lymphoma Test Validation Program​
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.